This week, GOLD speaks to Kumaran Krishnan, Director, Medical Excellence and Digital Transformation, Teva Pharmaceuticals, about unlocking further potential in developed markets, the impact of COVID-19 on MSL KPIs, and building medical affairs teams that are fit for the future.
Talking to Kumaran Krishnan
17 Nov 2020
EMJ GOLD
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Thank you!
Please share some more information on the rating you have given